1. Introduction {#sec0001}
===============

1.1. Research motivation {#sec0002}
------------------------

COVID-19 is a global pandemic that has resulted in 1484,811 infected cases and 88,538 deaths as of April 9, 2020 (WHO), and researchers predict that global mortality will be massive, as in [@bib0032] and [@bib0003]. Countries worldwide have begun to implement actions to mitigate infections and deaths. These actions can be categorized into four types: social distancing, home quarantine, school closures, and case isolation.

However, whether these actions are effective in reducing the number of global cases and mortality remains unanswered, particularly from a global perspective. Investigating the global perspective is crucial, as it would enable countries to collaborate on the next pandemic, as mentioned in [@bib0033], Mendes (2020), [@bib0026]. In other words, questions remain regarding how these actions affect the total mortality damage of COVID-19 outside of China, the US, or the UK, which will be tremendous. Hence, to better design a set of policies that enables the reduction of cases and mortalities, this question must be addressed.

Thus, this study empirically examines the effectiveness of these actions for mitigating loss of mortality benefits, which is the monetized value of small changes in the number of mortalities aggregated to express the value related to one death in a population ([@bib0031]). This is a crucial parameter for policy evaluation in the global context. We use county-level mortality data on COVID-19 from January 2020, project the number of mortalities until September 2020, and calculate the global mortality benefits, which is the monetized value of the decreased number of mortalities.

1.2. Theoretical framework {#sec0003}
--------------------------

Our study contributes to two strands of literature. First, it contributes by examining the global monetized benefits of mortality during the COVID-19 pandemic. Because maintaining the lowest mortality possible should be the highest priority for all governments regardless of borders, our results are essential as they provide evidence that global actions during epidemics are essential because they provide substantial economic benefits that enable countries to mitigate inevitable economic downturns. However, we also find that previous works evaluating these actions mainly focused on the US, UK, and China. For example, previous works mentioned that these actions were effective in China in containing the number of mortalities and infected cases, as in [@bib0025], and reduced peak healthcare demand by 2/3 in the US and UK, as in [@bib0024], which could save 7.9 trillion USD in the US ([@bib0019]). Furthermore, [@bib0020] argued that these actions could substantially reduce the number of mortalities in Wuhan, China. Thus, we contribute by incorporating countries other than the US, UK, and China and by providing global estimates and implications. In this sense, our study is closely related to that of [@bib0002], which analyzes the impact of lockdown on the world economy.

Second, our result contributes by calculating the value of lives. Previous research considers diverse perspectives on the impact of COVID-19 in various sectors: (Wang, M., & Flessa, S. (2020). It computes the spread of the disease and simulates the effects of interventions on health using dynamic system models. [@bib0016] examine how COVID-19 can affect healthcare supply systems. [@bib0023] investigates how the global economy is affected by comparing economic conditions during SARS and the 2008--2009 financial crisis. [@bib0007] calculate the overall relative risk of the importation and exportation of COVID-19 from every airport to local municipalities around the world. While it is also essential to recognize the impacts of COVID-19 on diverse sectors, the disease ultimately and closely affects people\'s lives. Thus, our essential contribution is that we offer an approach for computing quantitative estimates of the effects of various actions on the value of lives. Therefore, it is relatively easy to understand which actions are more effective in reducing the cases and mortalities.

The remainder of this paper is structured as follows. [Section 1](#sec0001){ref-type="sec"} provides background in terms of policy, and [Section 2](#sec0004){ref-type="sec"} presents the model and introduces the data used in this study. [Section 3](#sec0007){ref-type="sec"} shows the empirical results. [Section 4](#sec0008){ref-type="sec"} discusses practical implications, and Section 5 concludes.

2. Methodology {#sec0004}
==============

2.1. Scenario settings {#sec0005}
----------------------

We establish two scenarios before computing the number of mortalities and the global mortality benefits. First, we establish a scenario involving the most aggressive form of social distancing, with all four additional actions included (social distancing, home quarantine, closure of schools, and case isolation), as the Action Scenario. We establish another scenario, the Nonaction Scenario, which does not include any of the actions included in the Action Scenario and depends on a form of "herd immunity." The Nonaction Scenario does not mean that a country is not taking any actions to mitigate mortalities. Instead, it refers to a hypothetical situation in which countries are not implementing the four actions above.[1](#cit_1){ref-type="fn"} We assume that all measures started in late March and that COVID-19 will persist until late September. Then, we compare the projected number of mortalities and global mortality benefits of the two scenarios to draw implications on the monetized benefits of executing all four actions.

2.2. Empirical analysis {#sec0006}
-----------------------

Computing the global mortality benefits starts with projecting the global number of mortalities. To do so, we refer to the transmission model and health care demand from [@bib0024] and [@bib0019] using basic reproduction numbers with country-level data. We develop a model that predicts the daily number of infected cases and mortalities under simple assumptions. First, we assume that the number of infected cases and mortalities follows the normal distribution, which approximates the growth curves for the epidemic. The center or peak of the distribution, for instance, would correspond to the peak of the daily number of new infected cases. Then, we compute the number of mortalities based on the number of projected infected cases and the infection fatality ratio (IFR) from [@bib0027] To acquire the number of mortalities based on age group, we adjust for the age distribution of each country, referring to World Bank data. We determine nine age groups and their distributions for each country, and we adopt the same distribution for the total number of mortalities. Using the number of mortalities, we calculate the reduction in mortality from the Nonaction Scenario to the Action Scenario and compute the global mortality benefit using age-varying and country-specific estimates of the value of a statistical life (VSL), referring to [@bib0019], Viscusi and Masterman (2020), [@bib0009], and [@bib0017].[2](#cit_2){ref-type="fn"}

Our model calculates direct deaths with a simple model structure instead of directly including intensive care unit (ICU) bed demand overflow. As a result of this simple structure and the many places that are currently replacing the ICU in practice globally, our model is applicable to discussions of important social aspects with a focus on the direct number of mortalities. [@bib0024] and [@bib0019] apply a more complex model by adopting the demand overflow of ICU beds, but this would require more assumptions, and the number of assumptions would increase if we broadened the research scope to include the entire world.

First, the demand for ICU beds is subject to change. For the Chinese data on ICUs, clinicians noted that only half of the patients seemed to need invasive mechanical ventilators; the others were given pressurized oxygen and may not have needed an ICU bed, as mentioned in [@bib0005]. Furthermore, the demand for ICU beds is subject to change according to the efficiency of bed management in hospitals, as in[@bib0006]. Second, ICU beds are not available in low-income countries (i.e., Cambodia, Congo, Ethiopia, Kenya, Nepal, and Uganda). These low-income countries lack ICU beds, and more than 50% of these countries lack any published data on ICU capacity, as mentioned in ([@bib0028]). Third, referring to [@bib0008], as the pandemic persists, countries increase their adaptation capability, which works globally to reduce adverse effects (i.e., mortalities) in general. Increased adaptation capability would reduce ICU bed demand, requiring more complex assumptions, whereas we focus on implications in the simple but global context. Therefore, in this study, we focus on the number of direct deaths and discuss global implications.

3. Results {#sec0007}
==========

Our calculated global mortality benefit shows that adopting the most aggressive form of action would save approximately USD 40.76 trillion globally. Considering that the global GDP in 2018 was approximately 85.91 trillion USD (World Bank), our results show a savings of approximately 47.44% of the GDP as a result of taking action. This result indicates that world populations are willing to pay USD 40.76 trillion for mortality risk reductions. Our results also show that social distancing has the most substantial effects of saving USD 14.79 trillion for mortality risk reductions, which is 17.22% of the global GDP.

Panel (A) in [Fig. 1](#fig0001){ref-type="fig"} shows the global distribution of global mortality benefits through a map. Our estimates suggest that the US would share the most benefit, approximately 17.71%, at the continent level. At the country level, Japan and China would benefit the most, as they share 12.64% and 11.96%, respectively, of the benefits of avoided damages worldwide. European countries also receive a large portion of the benefits: Germany has the highest savings, with 7.92%, followed by France (5.20%), the UK (5.00%), and Italy (4.37%). On the other hand, countries with the least benefits are mainly those on the African continent, for example, Gambia, Central African Republic, and Rwanda. Panel (B) in [Fig. 1](#fig0001){ref-type="fig"} indicates the global distribution of GDP loss due to nonaction. We calculate the GDP loss by calculating the global mortality benefit before the COVID-19 outbreak and then subtract it from the global mortality benefit after the COVID-19 outbreak. Then, we divide the difference between the two by the GDP. In Panel (A), our results indicate that the global average of GDP loss would be 35.61%. Global loss due to nonaction was highest in Japan and European countries and low in African countries. One interesting finding here is that, while the US shows a relatively high global mortality benefit in Panel (A), our estimates suggest that the GDP loss after COVID-19 in the US would also be substantial (34.61%).Fig. 1Panel (A): Global Distribution of Global Mortality Benefits (in Trillion USD) A higher number (blue color) indicates that the benefits of actions (case isolation, home quarantine, school closure and social distancing) are high. Lower values (green colors) suggest that the estimated mortality benefit is lower. Panel (B): GDP Loss after COVID-19 in the Nonaction Scenario (%). A higher number indicates that the GDP loss is high. Lower values suggest that the estimated GDP loss is low.Fig. 1

[Fig. 2](#fig0002){ref-type="fig"} shows the distribution of global mortality benefits by action. Among all types of actions, social distancing has the most significant benefits. Social distancing accounts for 55% of the benefit (USD 14.71 trillion), followed by home quarantine, school closures, and case isolation, which account for 23% (USD 6.08 trillion), 21% (USD 5.59 trillion), and 2% (USD 0.49 trillion), respectively. Our findings are consistent with Ferguson and Greenstone, who show that the benefits of social distancing are substantial. However, this is not to say that other actions are a futile endeavor; given a choice between nonaction and action, countries worldwide would prefer to take action. Therefore, there is still a need to promote actions that yield lower benefits than social distancing.Fig. 2Global Mortality Benefits by Action, expressed in trillion USD. The label on the bar graph refers to the monetized value of each action. For example, social distancing shows a global mortality benefit of 14.79 trillion USD.Fig. 2

[Figs. 3](#fig0003){ref-type="fig"} , [4](#fig0004){ref-type="fig"} , and [5](#fig0005){ref-type="fig"} show the portion of global benefits for national GDP by country and scenario, expressed in maps; the projected number of mortalities by country and scenario; and the GDP loss of action scenarios, respectively. Panel (A) shows the result of Action Scenario 1, which includes case isolation, home quarantine, and social distancing; Panel (B) displays the result of Action Scenario 2, which includes school closure, case isolation, and social distancing; Panel (C) presents the result of Action Scenario 3, which includes case isolation, school closure, home quarantine, and social distancing. We further provide the specific rankings for each figure in Appendix [Tables A1](#tbl0001){ref-type="table"} , [A2](#tbl0002){ref-type="table"} and [A3](#tbl0003){ref-type="table"} .Fig. 3The Portion of Global Benefits for National GDP by Country and Scenario, Expressed in Maps.Fig. 3Fig. 4The Projected Number of Mortalities by Country and Scenario, Expressed in Maps (Projected until Late September).Fig. 4Fig. 5The GDP Loss of Action Scenarios by Countries and Scenarios Expressed in Maps.Fig. 5Table A1Portion of Global Benefits to National GDP by Country and Scenario. (A): A list of the countries included in this study (alphabetical order). (B-a): The portion of benefits to the national GDP **by country for** Action Scenario 1, which includes case isolation, home quarantine, and social distancing. (B-b): The portion of benefits to the national GDP **by country** for Action Scenario 2, which includes **school closure, case isolation, and social distancing**. (B-c): The portion of benefits to the national GDP **by countr**y for Action Scenario 3, which includes case isolation, school closure, home quarantine, and social distancing.Table A1(A) Countries(B) Benefits from Actions (% to National GDP)(B-a) Action Scenario 1(B-b) Action Scenario 2(B-c) Action Scenario 3Afghanistan11.40%13.30%13.40%Albania38.10%44.20%44.80%Algeria27.20%31.60%32.00%Angola10.60%12.30%12.40%Antigua and Barbuda27.90%32.40%32.80%Argentina39.20%45.50%46.00%Armenia37.60%43.60%44.20%Australia54.40%63.10%63.90%Austria58.40%67.80%68.60%Azerbaijan35.30%41.00%41.50%Bahamas17.10%19.90%20.10%Bahrain10.80%12.50%12.70%Bangladesh13.80%16.10%16.30%Barbados44.30%51.40%52.10%Belarus51.70%60.00%60.80%Belgium58.50%67.90%68.70%Belize16.40%19.10%19.30%Benin11.00%12.80%12.90%Bhutan15.90%18.50%18.70%Bolivia21.30%24.70%25.00%Bosnia and Herzegovina42.60%49.50%50.10%Brazil33.10%38.40%38.90%Brunei Darussalam24.20%28.10%28.50%Bulgaria52.60%61.00%61.70%Burkina Faso8.10%9.50%9.60%Cambodia11.90%13.80%13.90%Cameroon8.60%10.00%10.10%Canada59.20%68.80%69.60%Central African Republic7.10%8.20%8.30%Chad10.90%12.60%12.80%Chile35.60%41.30%41.80%China30.50%35.40%35.80%Colombia32.50%37.70%38.20%Congo12.50%14.50%14.70%Costa Rica30.00%34.80%35.30%Côte d\'Ivoire8.60%10.00%10.10%Croatia56.80%66.00%66.80%Cyprus56.90%66.10%66.90%Czech Republic47.30%54.90%55.60%Democratic Republic of the Congo7.90%9.20%9.30%Denmark59.90%69.50%70.40%Dominican Republic20.10%23.40%23.70%Ecuador24.40%28.30%28.70%Egypt24.10%28.00%28.30%El Salvador27.90%32.30%32.70%Equatorial Guinea11.70%13.60%13.80%Estonia51.00%59.20%60.00%Ethiopia9.50%11.00%11.20%Fiji15.40%17.90%18.10%Finland64.10%74.40%75.30%France64.90%75.40%76.30%Gabon15.10%17.50%17.70%Gambia6.00%7.00%7.10%Georgia43.40%50.30%50.90%Germany69.60%80.80%81.80%Ghana8.20%9.50%9.60%Greece74.10%86.00%87.10%Grenada26.30%30.50%30.90%Guatemala13.80%16.00%16.20%Guinea5.50%6.40%6.50%Guyana20.20%23.50%23.80%Haiti16.50%19.20%19.40%Honduras16.20%18.80%19.00%Hungary48.70%56.50%57.20%Iceland33.40%38.80%39.30%India2.50%3.00%3.00%Indonesia19.70%22.80%23.10%Iran27.00%31.30%31.70%Iraq12.10%14.10%14.20%Ireland30.60%35.60%36.00%Israel33.40%38.80%39.30%Italy72.80%84.50%85.50%Jamaica29.20%33.80%34.30%Japan88.20%102.40%103.70%Jordan16.40%19.00%19.20%Kazakhstan31.50%36.60%37.10%Kenya7.70%8.90%9.00%Kuwait19.20%22.30%22.60%Kyrgyzstan16.30%18.90%19.10%Laos10.40%12.10%12.30%Latvia55.20%64.00%64.80%Lebanon24.20%28.10%28.50%Liberia6.70%7.80%7.90%Lithuania52.60%61.00%61.80%Luxembourg31.80%36.90%37.40%Madagascar9.10%10.50%10.70%Malaysia22.70%26.30%26.60%Maldives9.80%11.40%11.60%Mali7.60%8.80%8.90%Malta53.00%61.50%62.20%Mauritania13.70%15.90%16.10%Mauritius34.70%40.20%40.70%Mexico26.30%30.50%30.90%Mongolia15.90%18.50%18.70%Montenegro39.90%46.30%46.80%Morocco23.60%27.50%27.80%Mozambique12.10%14.10%14.20%Myanmar18.80%21.80%22.10%Namibia11.60%13.40%13.60%Nepal13.70%15.90%16.10%Netherlands58.00%67.30%68.10%New Zealand49.60%57.60%58.30%Nicaragua19.20%22.20%22.50%Niger8.60%10.00%10.10%Nigeria13.90%16.10%16.30%Norway63.60%73.90%74.80%Oman11.90%13.80%13.90%Pakistan15.20%17.60%17.80%Panama22.40%26.00%26.30%Papua New Guinea10.70%12.40%12.50%Paraguay16.30%18.90%19.10%Peru25.70%29.90%30.20%Philippines22.10%25.60%25.90%Poland50.70%58.80%59.50%Portugal64.00%74.30%75.20%Puerto Rico40.60%47.10%47.70%Qatar12.50%14.50%14.60%Republic of Korea46.10%53.50%54.10%Romania46.30%53.80%54.40%Russian Federation50.10%58.10%58.80%Rwanda10.30%12.00%12.10%Saint Lucia23.60%27.40%27.80%Saint Vincent and the Grenadines29.50%34.30%34.70%Saudi Arabia14.90%17.20%17.50%Senegal7.10%8.30%8.40%Serbia43.30%50.20%50.80%Seychelles26.20%30.40%30.80%Singapore34.80%40.40%40.90%Slovakia46.30%53.70%54.40%Slovenia55.30%64.20%64.90%South Africa18.10%21.00%21.20%Spain62.60%72.60%73.50%Sri Lanka32.80%38.10%38.50%Sudan25.50%29.60%30.00%Suriname37.40%43.40%44.00%Sweden67.70%78.60%79.50%Switzerland63.80%74.10%75.00%Thailand34.00%39.50%40.00%Timor Leste16.00%18.60%18.80%Togo8.50%9.90%10.00%Trinidad and Tobago38.10%44.30%44.80%Tunisia34.50%40.10%40.60%Turkey31.80%36.90%37.30%Uganda8.40%9.70%9.80%Ukraine48.50%56.30%57.00%United Arab Emirates9.50%11.10%11.20%United Kingdom60.70%70.50%71.30%United States of America28.00%32.50%32.90%Uruguay45.30%52.60%53.20%Uzbekistan25.50%29.60%30.00%Vietnam22.10%25.60%25.90%Zambia8.10%9.40%9.50%Zimbabwe4.40%5.10%5.10%Table A2Projected Number of Mortality by Country and Scenario (Projected until Late September). (A): A list of the countries included in this study (alphabetical order). (B-a): The number of projected mortalities in the Nonaction scenario until late September. (B-b): The number of projected mortalities in Action Scenario 1, which includes case isolation, school closure, and social distancing. (B-c): The number of projected mortalities in Action Scenario 2, which includes school closure, case isolation, and social distancing. (B-d): The number of projected mortalities in Action Scenario 3, which includes case isolation, school closure, home quarantine, and social distancing.Table A2(A) Countries(B) Projected Number of Mortalities(B-a) Nonaction(B-b) Action Scenario 1(B-c) Action Scenario 2(B-d) Action Scenario 3Afghanistan25,3534325943646Albania94231608351240Algeria67,96311,59525281732Angola18,6503182694475Antigua and Barbuda2384196Argentina114,45419,52642582917Armenia84341439314215Australia90,96815,51933842319Austria39,271670014611001Azerbaijan17,6803016658451Bahamas7181222718Bahrain14362455337Bangladesh222,92038,03082935682Barbados11011884128Belarus33,47157101245853Belgium50,242857118691281Belize479821812Benin94481612351241Bhutan11481964329Bolivia20,0243416745510Bosnia and Herzegovina12,8992201480329Brazil446,93376,24716,62611,392Brunei Darussalam6061032315Bulgaria32,06154701193817Burkina Faso12,5772146468321Cambodia19,0593252709486Cameroon17,6173006655449Canada149,58425,51955653813Central African Republic331156512384Chad97561664363249Chile52,720899419611344China3666,538625,511136,39593,460Colombia105,51218,00039252690Congo388466314499Costa Rica12,1552074452310Côte d\'Ivoire18,3083123681467Croatia19,1213262711487Cyprus383065314298Czech Republic44,795764216661142Democratic Republic of the Congo63,43510,82223601617Denmark25,4894348948650Dominican Republic19,3333298719493Ecuador30,74052441144784Egypt126,64521,60647113228El Salvador12,9012201480329Equatorial Guinea8581463222Estonia59841021223153Ethiopia94,51216,12435162409Fiji12392114632Finland26,6914554993680France311,64153,16611,5937944Gabon19283297249Gambia14932555638Georgia12,8442191478327Germany419,02671,48615,58810,681Ghana25,2234303938643Greece55,712950420721420Grenada2524396Guatemala21,0473591783536Guinea89571528333228Guyana13422295034Haiti13,8482362515353Honduras11,9312035444304Hungary41,499708015441058Iceland12082064531India308,14052,56911,4637854Indonesia417,01071,14215,51310,630Iran132,26122,56449203371Iraq32,63255671214832Ireland15,6182664581398Israel24,2614139903618Italy323,88155,25412,0488256Jamaica63541084236162Japan791,482135,02729,44320,175Jordan10,3461765385264Kazakhstan34,78159341294887Kenya35,10059881306895Kuwait4494767167115Kyrgyzstan79021348294201Laos75451287281192Latvia88791515330226Lebanon12,4642126464318Liberia4050691151103Lithuania13,1742248490336Luxembourg20523507652Madagascar21,0003583781535Malaysia53,815918120021372Maldives528902013Mali11,9022030443303Malta22573858458Mauritania366562513693Mauritius352960213190Mexico231,55439,50386145902Mongolia376364214096Montenegro21293637954Morocco64,49411,00323991644Mozambique20,9973582781535Myanmar80,54813,74229962053Namibia22613868458Nepal38,07164951416970Netherlands75,97712,96228261937New Zealand17,7893035662453Nicaragua90661547337231Niger14,3482448534366Nigeria137,38123,43751113502Norway20,6503523768526Oman389066414599Pakistan231,79939,54586235909Panama85771463319219Papua New Guinea78451338292200Paraguay11,0211880410281Peru65,24811,13124271663Philippines143,94424,55753553669Poland155,86226,59057983973Portugal52,588897219561340Puerto Rico14,8942541554380Qatar19883397451Republic of Korea190,49932,49970874856Romania81,84613,96330452086Russian Federation507,69586,61318,88612,941Rwanda98431679366251Saint Lucia433741611Saint Vincent and the Grenadines2534396Saudi Arabia34,73759261292885Senegal12,2672093456313Serbia27,68847241030706Seychelles1983475Singapore17,0342906634434Slovakia19,5373333727498Slovenia94271608351240South Africa76,67713,08128521954Spain218,11237,21081145560Sri Lanka53,721916519981369Sudan37,99464821413968Suriname10051723726Sweden45,528776716941161Switzerland37,24863551386949Thailand210,55335,92078335367Timor Leste13262264934Togo58901005219150Trinidad and Tobago360561513492Tunisia24,2084130901617Turkey172,50229,42964174397Uganda23,0343930857587Ukraine168,54128,75362704296United Arab Emirates64161095239164United Kingdom279,86647,74510,4117134United States of America731,068124,72027,19618,635Uruguay12,0332053448307Uzbekistan41,694711315511063Vietnam190,62032,52070914859Zambia10,1071724376258Zimbabwe11,0041877409280Table A3GDP Loss of Action Scenarios by Countries and Scenarios Expressed in Table. (A): A list of countries included in this study (alphabetical order). (B-a): The GDP loss from the Nonaction Scenario. (B-b): The GDP loss of Action Scenario 1, which includes case isolation, home quarantine, and social distancing. (B-c): The GDP loss of Action Scenario 2, which includes school closure, case isolation, and social distancing. (B-d): the GDP loss of Action Scenario 3, which includes case isolation, school closure, home quarantine, and social distancing.Table A3(A) Countries(B) GDP Loss (% of National GDP)(B-a) Nonaction(B-b) Action Scenario 1(B-c) Action Scenario 2(B-d) Action Scenario 3Afghanistan13.787%2.350%0.514%0.351%Albania45.936%7.836%1.710%1.172%Algeria32.807%5.596%1.220%0.836%Angola12.726%2.171%0.473%0.325%Antigua and Barbuda33.689%5.747%1.252%0.859%Argentina47.221%8.056%1.756%1.203%Armenia45.327%7.733%1.687%1.156%Australia65.582%11.190%2.441%1.672%Austria70.370%12.005%2.618%1.794%Azerbaijan42.550%7.258%1.583%1.084%Bahamas20.625%3.519%0.768%0.526%Bahrain12.992%2.217%0.483%0.331%Bangladesh16.690%2.846%0.620%0.425%Barbados53.432%9.116%1.987%1.361%Belarus62.342%10.635%2.320%1.589%Belgium70.484%12.024%2.622%1.797%Belize19.795%3.377%0.735%0.503%Benin13.263%2.262%0.493%0.338%Bhutan19.212%3.277%0.714%0.489%Bolivia25.665%4.379%0.956%0.654%Bosnia and Herzegovina51.383%8.767%1.912%1.309%Brazil40.658%6.936%1.512%1.036%Brunei Darussalam29.215%4.984%1.087%0.744%Bulgaria63.361%10.810%2.358%1.615%Burkina Faso9.825%1.676%0.365%0.250%Cambodia14.306%2.441%0.532%0.365%Cameroon10.368%1.769%0.385%0.264%Canada71.421%12.185%2.658%1.821%Central African Republic8.527%1.454%0.317%0.218%Chad13.113%2.235%0.486%0.333%Chile42.898%7.318%1.595%1.093%China36.763%6.272%1.368%0.937%Colombia39.158%6.679%1.457%0.998%Congo15.108%2.577%0.562%0.386%Costa Rica36.178%6.172%1.345%0.921%Côte d\'Ivoire10.415%1.778%0.388%0.266%Croatia68.530%11.691%2.549%1.747%Cyprus68.618%11.708%2.554%1.751%Czech Republic57.020%9.728%2.120%1.453%Democratic Republic of the Congo9.564%1.631%0.356%0.244%Denmark72.198%12.318%2.687%1.841%Dominican Republic24.286%4.144%0.904%0.619%Ecuador29.427%5.020%1.094%0.749%Egypt29.061%4.958%1.081%0.740%El Salvador33.588%5.732%1.251%0.858%Equatorial Guinea14.132%2.410%0.525%0.359%Estonia61.522%10.496%2.289%1.568%Ethiopia11.452%1.954%0.426%0.292%Fiji18.610%3.175%0.692%0.474%Finland77.256%13.179%2.873%1.969%France78.273%13.354%2.911%1.995%Gabon18.150%3.097%0.676%0.466%Gambia7.245%1.236%0.270%0.186%Georgia52.269%8.918%1.945%1.332%Germany83.908%14.314%3.121%2.138%Ghana9.831%1.678%0.366%0.252%Greece89.341%15.242%3.324%2.277%Grenada31.663%5.402%1.178%0.808%Guatemala16.598%2.832%0.618%0.423%Guinea6.670%1.138%0.249%0.170%Guyana24.379%4.159%0.907%0.622%Haiti19.951%3.402%0.742%0.509%Honduras19.535%3.333%0.728%0.499%Hungary58.702%10.015%2.184%1.496%Iceland40.280%6.872%1.498%1.027%India3.127%0.533%0.117%0.080%Indonesia23.706%4.044%0.881%0.603%Iran32.534%5.550%1.211%0.831%Iraq14.598%2.490%0.544%0.373%Ireland36.949%6.304%1.374%0.941%Israel40.308%6.877%1.499%1.028%Italy87.745%14.969%3.263%2.236%Jamaica35.157%5.998%1.308%0.896%Japan106.392%18.150%3.957%2.711%Jordan19.748%3.370%0.734%0.502%Kazakhstan38.039%6.490%1.416%0.970%Kenya9.247%1.578%0.345%0.237%Kuwait23.190%3.956%0.862%0.592%Kyrgyzstan19.650%3.352%0.732%0.500%Laos12.584%2.147%0.469%0.322%Latvia66.508%11.347%2.475%1.696%Lebanon29.199%4.982%1.088%0.745%Liberia8.083%1.379%0.301%0.206%Lithuania63.380%10.812%2.357%1.615%Luxembourg38.362%6.544%1.426%0.978%Madagascar10.940%1.866%0.406%0.280%Malaysia27.315%4.659%1.015%0.695%Maldives11.872%2.026%0.442%0.303%Mali9.117%1.556%0.339%0.232%Malta63.846%10.893%2.376%1.628%Mauritania16.562%2.825%0.616%0.423%Mauritius41.780%7.127%1.554%1.065%Mexico31.717%5.411%1.181%0.809%Mongolia19.201%3.275%0.716%0.490%Montenegro48.062%8.199%1.788%1.225%Morocco28.514%4.864%1.060%0.728%Mozambique14.593%2.489%0.542%0.370%Myanmar22.639%3.863%0.843%0.579%Namibia13.931%2.377%0.520%0.356%Nepal16.534%2.820%0.615%0.422%Netherlands69.913%11.927%2.602%1.783%New Zealand59.780%10.199%2.223%1.524%Nicaragua23.104%3.941%0.860%0.589%Niger10.385%1.772%0.386%0.264%Nigeria16.821%2.870%0.626%0.429%Norway76.721%13.088%2.854%1.957%Oman14.295%2.440%0.532%0.365%Pakistan18.299%3.122%0.680%0.465%Panama26.965%4.601%1.004%0.689%Papua New Guinea12.876%2.196%0.479%0.328%Paraguay19.639%3.351%0.731%0.501%Peru31.019%5.293%1.155%0.791%Philippines26.605%4.540%0.991%0.679%Poland61.086%10.421%2.272%1.556%Portugal77.183%13.168%2.870%1.968%Puerto Rico48.958%8.353%1.821%1.248%Qatar15.025%2.563%0.558%0.383%Republic of Korea55.566%9.480%2.067%1.417%Romania55.837%9.526%2.077%1.424%Russian Federation60.353%10.296%2.245%1.539%Rwanda12.450%2.124%0.464%0.318%Saint Lucia28.497%4.861%1.060%0.726%Saint Vincent and the Grenadines35.610%6.076%1.325%0.909%Saudi Arabia17.916%3.058%0.667%0.458%Senegal8.614%1.468%0.320%0.219%Serbia52.158%8.898%1.940%1.329%Seychelles31.571%5.387%1.175%0.804%Singapore41.928%7.153%1.560%1.069%Slovakia55.778%9.516%2.075%1.422%Slovenia66.649%11.371%2.479%1.700%South Africa21.798%3.719%0.810%0.556%Spain75.447%12.871%2.806%1.924%Sri Lanka39.536%6.745%1.470%1.007%Sudan30.755%5.248%1.146%0.788%Suriname45.109%7.697%1.681%1.152%Sweden81.599%13.920%3.036%2.080%Switzerland76.923%13.124%2.861%1.960%Thailand41.037%7.002%1.527%1.047%Timor Leste19.297%3.291%0.717%0.492%Togo10.248%1.748%0.381%0.261%Trinidad and Tobago45.967%7.842%1.710%1.172%Tunisia41.612%7.098%1.547%1.061%Turkey38.306%6.534%1.425%0.975%Uganda10.105%1.722%0.375%0.257%Ukraine58.496%9.979%2.175%1.492%United Arab Emirates11.495%1.962%0.429%0.294%United Kingdom73.183%12.485%2.721%1.865%United States of America34.365%5.863%1.277%0.875%Uruguay54.630%9.319%2.032%1.391%Uzbekistan30.747%5.246%1.145%0.786%Vietnam26.600%4.538%0.990%0.679%Zambia9.717%1.660%0.363%0.249%Zimbabwe5.267%0.898%0.196%0.135%

Regarding age group, the 60- to 69-year-old age group would experience the most benefits, at 21.70%; the 50- to 59-year age group would experience 7.42%; and 40- to 49-year-olds would experience 1.92%. This result shows that the number of cases, the number of deaths and the willingness to pay to reduce risk to life are higher for the 60- to 69-year-old age group than for the other age groups.

4. Discussion {#sec0008}
=============

The estimates for each country are worth highlighting. First, we find that the overall benefits are focused on developed countries. The top 10 countries with the greatest benefits include the US, Japan, China, Germany, France, and the UK. The total global mortality of the top 3 countries (the US, Japan, and China) would be 16.78 trillion USD, which is more than 40% of the total global mortality benefits and accounts for approximately 20% of the global GDP for 2018. Such vast benefits cannot be easily derived from policy interventions, which implies that the economic benefits of taking actions are substantial. This result also suggests that the people in these three countries value their lives and are therefore willing to pay a large amount of money to reduce risks.

Second, the bottom ten countries with the least benefits include Gambia, the Central African Republic, Liberia, Rwanda, and Togo (all less than 1%), which are mainly situated on the African continent. This result is due to the small number of cases in Africa until late March. It is questionable whether African countries have fewer cases than Europe or Asia because African countries do not have the medical capability to count confirmed cases. Because of the high volume of air traffic and trade between China and Africa, Africa is at high risk for the introduction and spread of COVID-19, as mentioned in [@bib0012]. [@bib0021] mentioned that once the first cases were confirmed in West Africa, the increase in the number of confirmed cases of COVID-19 was rapid. However, [@bib0014] and [@bib0010] argue that Africa should be safer from COVID-19 because its high temperature and humidity can reduce the number of cases. If the virus that causes COVID-2019 is weakened by warm temperatures, then the environmental factors of countries with high temperatures and humidity can maximize the benefits of social distancing and can further prevent cases and deaths. However, other strands of research, including Xie et al. (2020) and [@bib0029], argue that temperature is not correlated with the sensitivity of COVID-19.

From a policy perspective, it is necessary to keep the public informed of the benefits of actions in terms of reducing cases and mortalities and maximizing global economic benefits. Actions, including social distancing, home quarantine, school closure and case isolation, are vital not only for global mortality benefits but also for preventing mortality and GDP loss. In this case, to maximize the benefits and mitigate cases and deaths, raising awareness of social distancing is required. Because this is a benefit-of-life value, which is challenging to monetize, there is room for our estimates to be increased if pandemics persist and people place more importance on the value of a life over this time, as in [@bib0011].

In this sense, our estimates are not overestimated; they are likely to represent the lower bound and leave room to increase because we did not consider additional benefits derived from social distancing. For example, [@bib0004] argue that social distancing can slow infection and can further reduce cases and improve the quality of medical care for non-COVID-19 symptoms. Our results are not limited to social distancing and highlight the importance of other measures. Measures such as school closure or home quarantine could be more feasible than social distancing measures, as in [@bib0018]. Pandemic plans need to consider how to facilitate such efforts because multiple actions would maximize the benefits and save more lives worldwide.

Conclusion {#sec0009}
==========

The COVID-19 outbreak indicates the need to evaluate the actions that governments worldwide are implementing to mitigate the number of mortalities and cases. The impact of these actions on the worldwide economy is estimated to be substantial. Our estimates suggest that at least 40.76 trillion USD can be saved globally. Economic loss due to reduced demand and supply as a result of COVID-19 has been discussed, but we show that reducing the loss of humans would be more significant because the total saved loss would be approximately 47.28% of the global annual GDP. Social distancing accounts for more than half of the estimates and would save 14.49 trillion USD globally. This amount is larger than the Chinese GDP and equivalent to approximately 2/3 of the US GDP. Our results show that these actions can produce substantial benefits worldwide.

Unfortunately, predicting the global mortality benefits a few months after the outbreak of COVID-19 does include the problem of uncertainty. However, we believe this research will provide guidelines and insights for researchers and policymakers by providing humble policy advice. Estimating more robust estimates with more data and over a longer period would boost the numerical precision of this research and should be a focus of future research.
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In this section, we provide the results tables for [Figs. 3](#fig0003){ref-type="fig"}, [4](#fig0004){ref-type="fig"} and [5](#fig0005){ref-type="fig"}.

[Table A1](#tbl0001){ref-type="table"}.

[Table A2](#tbl0002){ref-type="table"}

[Table A3](#tbl0003){ref-type="table"}.
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Of course, it is possible to include actions other than the four mentioned in [Section 2.1](#sec0005){ref-type="sec"}. Nevertheless, if none of the four actions mentioned in [Section 2.1](#sec0005){ref-type="sec"}. is included, we classify the scenario as a Nonaction Scenario.

Greenstone\'s mortality benefit for the US is 7.9 trillion USD using US VSL; our estimates produce a mortality benefit of 7.22 trillion USD after adopting international VSL.

[^1]: These authors contributed equally to this work.
